Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
Harish N Vasudevan, David R Raleigh, Julian Johnson, Adam A Garsa, Philip V Theodosopoulos, Manish K Aghi, Christopher Ames, Michael W McDermott, Igor J Barani, Steve E Braunstein, Harish N Vasudevan, David R Raleigh, Julian Johnson, Adam A Garsa, Philip V Theodosopoulos, Manish K Aghi, Christopher Ames, Michael W McDermott, Igor J Barani, Steve E Braunstein
Abstract
Objective: To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) for chordoma and chondrosarcoma.
Methods: Twenty consecutive patients with a histopathologic diagnosis of chordoma (n = 16) or chondrosarcoma (n = 4) treated between 2010 and 2016 were retrospectively identified. All patients underwent FSRT in five fractions to a median dose of 37.5 Gy (range: 25-40 Gy) and followed with serial magnetic resonance imaging. Overall survival (OS), local recurrence-free survival (LRFS), and event-free survival (EFS) were estimated using the Kaplan-Meier method.
Results: With a median follow-up of 28 months after FSRT and 40 months after initial surgery, crude OS and LRFS were 90%. Nine patients (45%) reported grade 1-3 acute toxicity, and two patients (10%) experienced grade 4, 5 late toxicity. One patient previously treated with proton therapy died from radiation vasculopathy 9 months after FSRT. The use of FSRT for recurrent disease or in patients with prior radiation therapy was associated with significantly decreased EFS.
Conclusion: FSRT for chordoma and chondrosarcoma is associated with high rates of OS and local control. Although many patients experience acute toxicity, there is a low incidence of late toxicity or irreversible treatment related morbidity despite the frequency of prior radiotherapy in this population. FSRT is an effective adjuvant or salvage treatment for chordoma and chondrosarcoma.
Keywords: CyberKnife; chondrosarcoma; chordoma; fractionated stereotactic radiotherapy; stereotactic body radiotherapy.
Figures
References
- Mcmaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control (2001) 12:1–11.10.1023/A:1008947301735
- Walcott BP, Nahed BV, Mohyeldin A, Coumans J, Kahle KT, Ferreira MJ. Chordoma: current concepts, management, and future directions. Lancet Oncol (2012) 13:e69–76.10.1016/S1470-2045(11)70337-0
- Gelderblom H, Hogendoorn P, Dijkstra S, Van Rijswijk C, Krol A, Taminiau A, et al. The clinical approach towards chondrosarcoma. Oncologist (2008) 13:320–9.10.1634/theoncologist.2007-0237
- Amichetti M, Amelio D, Cianchetti M, Giacomelli I, Scartoni D. The treatment of chordoma and chondrosarcoma of the skull base with particular attention to radiotherapy. Clin Oncol (2017) 2 Available from:
- Bohman L-E, Koch M, Bailey RL, Alonso-Basanta M, Lee JYK. Skull base chordoma and chondrosarcoma: influence of clinical and demographic factors on prognosis: a SEER analysis. World Neurosurg (2014) 82:806–14.10.1016/j.wneu.2014.07.005
- Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer (1973) 32:410–20.10.1002/10970142(197308)32:2<410::AID-CNCR2820320219>;2-S
- Muthukumar N, Kondziolka D, Lunsford D, Flickinger J. Stereotactic radiosurgery for chordoma and chondrosarcoma: further experiences. Int J Radiat Oncol Biol Phys (1998) 41:387–92.10.1016/S0360-3016(98)00051-0
- Sen CN, Sekhar LN, Schramm VL, Janecka IP. Chordoma and chondrosarcoma of the cranial base: an 8-year experience. Neurosurgery (1989) 25:931–40.10.1227/00006123-198912000-00013
- Amendola BE, Amendola MA, Oliver E, McClatchey KD. Chordoma: role of radiation therapy. Radiology (1986) 158:839–43.10.1148/radiology.158.3.3945761
- Chang SD, Martin DP, Lee E, Adler JR, Jr. Stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for residual or recurrent cranial base and cervical chordomas. Neurosurg Focus (2001) 10:E5.10.3171/foc.2001.10.3.6
- Gay E, Sekhar L, Rubinstein E, Wright D, Sen C, Janecka I, et al. Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery (1995) 36:887–96.10.1097/00006123-199505000-00001
- Lanzino G, Dumont AS, Lopes MB, Laws ER. Skull base chordomas: overview of disease, management options, and outcome. Neurosurg Focus (2001) 10:E12.10.3171/foc.2001.10.3.13
- Samii A, Gerganov VM, Herold C, Hayashi N, Naka T, Mirzayan MJ, et al. Chordomas of the skull base: surgical management and outcome. J Neurosurg (2007) 107:319–24.10.3171/JNS-07/08/0319
- Tzortzidis F, Elahi F, Wright D, Natarajan SK, Sekhar LN. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery (2006) 59:230–7.10.1227/01.NEU.0000223441.51012.9D
- Higinbotham NL, Phillips RF, Farr HW, Hustu HO. Chordoma. Thirty-five-year study at Memorial Hospital. Cancer (1967) 20:1841–50.10.1002/1097-0142(196711)20:11<1841::AID-CNCR2820201107>;2-2
- Tewfik HH, McGinnis WL, Nordstrom DG, Latourette HB. Chordoma: evaluation of clinical behavior and treatment modalities. Int J Radiat Oncol Biol Phys (1977) 2:959–62.10.1016/0360-3016(77)90194-8
- Tai PT, Craighead P, Bagdon F. Optimization of radiotherapy for patients with cranial chordoma. A review of dose-response ratios for photon techniques. Cancer (1995) 75:749–56.10.1002/1097-0142(19950201)75:3<749::AID-CNCR2820750302>;2-D
- Ares C, Hug EB, Lomax AJ, Bolsi A, Timmermann B, Rutz HP, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys (2009) 75:1111–8.10.1016/j.ijrobp.2008.12.055
- Indelicato DJ, Rotondo RL, Begosh-Mayne D, Scarborough MT, Gibbs CP, Morris CG, et al. A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine. Int J Radiat Oncol Biol Phys (2016) 95:297–303.10.1016/j.ijrobp.2016.01.057
- Kim JH, Jung HH, Chang JH, Chang JW, Park YG, Chang WS. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes. J Neurosurg (2014) 121(Suppl):188–97.10.3171/2014.7.GKS141213
- Kondziolka D, Lunsford LD, Flickinger JC. The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery (1991) 29(1):38–45.10.1097/00006123-199107000-00007
- Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI. Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery (2005) 56:777–84.10.1227/01.NEU.0000156789.10394.F5
- Zorlu F, Gultekin M, Cengiz M, Yildiz F, Akyol F, Gurkaynak M, et al. Fractionated stereotactic radiosurgery treatment results for skull base chordomas. Technol Cancer Res Treat (2014) 13:11–9.10.7785/tcrt.2012.500354
- Sahgal A, Chan MW, Atenafu EG, Masson-Cote L, Bahl G, Yu E, et al. Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro Oncol (2015) 17:889–94.10.1093/neuonc/nou347
- Adler JR, Jr, Gibbs IC, Puataweepong P, Chang SD. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery (2006) 59:244–54.10.1227/01.NEU.0000223512.09115.3E
- Amichetti M, Amelio D, Minniti G. Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review. Radiat Oncol (2012) 7:1–12.10.1186/1748-717X-7-210
- Hasegawa T, Ishii D, Kida Y, Yoshimoto M, Koike J, Iizuka H. Gamma Knife surgery for skull base chordomas and chondrosarcomas. J Neurosurg (2007) 107:752–7.10.3171/JNS-07/10/0752
- Kano H, Igbal F, Sheehan J, Mathieu D, Seymour ZA, Niranjan A, et al. Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium. Neurosurgery (2011) 68:379–88.10.1227/NEU.0b013e3181ffa12c
- Martin JJ, Niranjan A, Kondziolka D, Flickinger JC, Lozanne KA, Lunsford LD. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg (2007) 107:758–64.10.3171/JNS-07/10/0758
- Sheybani A, Ahmed R, TenNapel M, Pennington EC, Hyer DE, Anderson KM, et al. Preliminary experience in treating skull base chordomas with high-dose hyperfractionated stereotactic photon radiation therapy. J Radiat Oncol (2014) 3:57–64.10.1007/s13566-013-0122-7
- Gwak H-S, Yoo H-J, Youn S-M, Chang U, Lee DH, Yoo S-Y, et al. Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: preliminary results. Stereotact Funct Neurosurg (2005) 83:233–43.10.1159/000091992
- Henderson FC, McCool K, Seigle J, Jean W, Harter W, Gagnon GJ. Treatment of chordomas with CyberKnife: Georgetown University experience and treatment recommendations. Neurosurgery (2009) 64:A44–53.10.1227/01.NEU.0000341166.09107.47
- Jiang B, Veeravagu A, Lee M, Harsh GR, Lieberson RE, Bhatti I, et al. Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery. J Clin Neurosci (2012) 19:1101–6.10.1016/j.jocn.2012.01.005
Source: PubMed